Table 2 Characteristics of the EPIC cohort subjects
PDAC | Controls | |||
|---|---|---|---|---|
N | % | N | % | |
Total | 16 | 100 | 32 | 100 |
Age (y) | ||||
Mean | 54.9 | 55.1 | ||
SD | 7.3 | 7.5 | ||
Sex | ||||
Female | 7 | 44 | 14 | 44 |
Male | 9 | 56 | 18 | 56 |
Time span to diagnosis (mo) | ||||
Mean | 61.2 | |||
Range | 5–117.1 | |||
PDAC | Controls | |||
|---|---|---|---|---|
N | % | N | % | |
Total | 16 | 100 | 32 | 100 |
Age (y) | ||||
Mean | 54.9 | 55.1 | ||
SD | 7.3 | 7.5 | ||
Sex | ||||
Female | 7 | 44 | 14 | 44 |
Male | 9 | 56 | 18 | 56 |
Time span to diagnosis (mo) | ||||
Mean | 61.2 | |||
Range | 5–117.1 | |||